SCHEMBL29362249

SCHEMBL29362249

C1=Cc2ncncc2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5799303 1.00
SCHEMBL9538730 0.78
SCHEMBL29909946 0.78
SCHEMBL611310 0.71 CDC25B (0.35)
SCHEMBL30605586 0.71 CDC25B (0.35)
SCHEMBL29476468 0.71 CDC25B (0.35)
SCHEMBL29903184 0.68
SCHEMBL29419946 0.68 GSK3A (0.39)
SCHEMBL23023244 0.65
SCHEMBL30118127 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120157686-A Compound with AKT kinase degradation activity, preparation method and pharmaceutical application thereof 南京正大天晴制药有限公司 2025-06-17 CN disclosed
CN-119302960-A Unit dose compositions of AKT inhibitors 南京正大天晴制药有限公司 2025-01-14 CN disclosed
CN-115916350-B Unit dose compositions of AKT inhibitors 南京正大天晴制药有限公司 2024-11-05 CN disclosed
CN-115485276-B Deuterated AKT kinase inhibitors 南京正大天晴制药有限公司 2024-05-31 CN disclosed
CN-117964620-A AKT inhibitors 南京正大天晴制药有限公司 2024-05-03 CN disclosed
CN-115916350-A Unit dose compositions of AKT inhibitors 南京正大天晴制药有限公司 2023-04-04 CN disclosed
CN-115843298-A Salt and crystal form of dihydropyrido [2,3-d ] pyrimidone derivative 南京正大天晴制药有限公司 2023-03-24 CN disclosed
CN-114907514-A Multifunctional fiber and preparation method and application thereof 北京洁尔爽高科技有限公司 2022-08-16 CN disclosed
WO-2022017448-A1 SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-D]PYRIMIDINE DERIVATE 南京正大天晴制药有限公司 2022-01-27 WO disclosed
WO-2022017449-A1 SALT OF DIHYDROPYRIDO[2,3-D]PYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 南京正大天晴制药有限公司 2022-01-27 WO disclosed